Lunabet Cream contains Luliconazole 1% w/w, a topical antifungal agent belonging to the imidazole class, indicated for the treatment of superficial fungal infections of the skin. Luliconazole exhibits potent fungicidal activity against dermatophytes, yeasts, and molds by inhibiting the biosynthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. Lunabet Cream is primarily prescribed for conditions such as tinea corporis, tinea cruris, and tinea pedis caused by susceptible strains of Trichophyton, Microsporum, and Epidermophyton species. The formulation is intended for external use and should be applied once daily to the affected area and surrounding skin after thorough cleansing and drying. Treatment duration typically ranges from one to two weeks, depending on the severity and location of the infection. Patients are advised to continue therapy for the full prescribed period even if symptoms improve earlier to prevent recurrence. Common adverse effects are generally mild and may include local irritation, burning sensation, or erythema at the application site. Lunabet Cream is contraindicated in individuals with known hypersensitivity to luliconazole or any excipients in the formulation. Use during pregnancy and lactation should be under medical supervision.